Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Sol-Gel Technologies Ltd.

Report top-line data from the Phase 1 SGT-210 proof-of-concept study

Delivered by the deadline

AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.

Announced
4 Mar 2021
Due
30 Sep 2021
Delivered
Q3 2021
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“The Company expects to report top-line data in the third quarter of 2021.”

What we found

Evidence strength A What the grades mean

Later 20-F filings state that during Q3 2021 the company reported the PPK proof-of-concept study was completed, with modest improvement and a favorable safety profile.

  • A
    Sol-Gel Technologies Ltd. 6-K filed 2021-11-16 Regulatory filing · published 16 Nov 2021 · retrieved 27 Oct 2026 · kept permanently by the SEC
    “A proof-of-concept clinical study in palmoplantar keratoderma patients indicated a potential modest improvement with a favourable safety profile” ✓ confirmed on the page
  • A
    Sol-Gel Technologies Ltd. 20-F filed 2022-04-04 Regulatory filing · published 4 Apr 2022 · retrieved 27 Oct 2026 · kept permanently by the SEC
    “During the third quarter of 2021, we reported that the study with respect to six (6) palmoplantar keratoderma (PPK) patients has been completed and indicated modest improvement and a favorable safety profile.” ✓ confirmed on the page
  • A
    Sol-Gel Technologies Ltd. 20-F filed 2022-04-04 Regulatory filing · published 4 Apr 2022 · retrieved 27 Oct 2026 · kept permanently by the SEC
    “During the third quarter of 2021, we reported that the study with respect to six (6) palmoplantar keratoderma (PPK) patients has been completed and indicated modest improvement and a favorable safety profile” ✓ confirmed on the page

Checked 27 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical readout
Indicative materiality
Medium rules
Action
Report
Deliverable
Top-line data from Phase 1 SGT-210 proof-of-concept study
Language
Expected (“expects”, “plans”)
In the company’s control
Medium
Specificity
High

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.

Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works

Are you Sol-Gel Technologies Ltd.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-SLGL-025130 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.